AHMED, NABIL M.,GOTTSCHALK, STEPHEN M.G.,WELS, WINFRIED
申请号：
CA2984624
公开号：
CA2984624A1
申请日:
2016.03.18
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
Embodiments of the disclosure include immune cells expressing HER2-specific chimeric antigen receptors (CAR) and treatment of cancer therewith. In specific embodiments, sarcoma or glioblastoma are treated. In specific embodiments, such as for glioblastoma, for example, T- cells expressing a HER2-specific CAR are pp65CMV- specific T cells.
